PortfoliosLab logoPortfoliosLab logo
SYNGENE.NS vs. 2269.HK
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

SYNGENE.NS vs. 2269.HK - Performance Comparison

The chart below illustrates the hypothetical performance of a ₹10,000 investment in Syngene International Limited (SYNGENE.NS) and WuXi Biologics (2269.HK). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SYNGENE.NS vs. 2269.HK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SYNGENE.NS
Syngene International Limited
-39.11%-24.02%22.60%19.99%-5.37%-3.08%99.78%14.48%3.66%16.66%
2269.HK
WuXi Biologics
14.20%86.87%-38.43%-50.19%-28.50%-7.98%219.55%102.76%24.85%52.87%
Different Trading Currencies

SYNGENE.NS is traded in INR, while 2269.HK is traded in HKD. To make them comparable, the 2269.HK values have been converted to INR using the latest available exchange rates.

Returns By Period

In the year-to-date period, SYNGENE.NS achieves a -39.11% return, which is significantly lower than 2269.HK's 14.20% return.


SYNGENE.NS

1D
1.67%
1M
-3.84%
YTD
-39.11%
6M
-37.24%
1Y
-44.70%
3Y*
-12.48%
5Y*
-6.48%
10Y*
7.78%

2269.HK

1D
0.00%
1M
-4.98%
YTD
14.20%
6M
-13.55%
1Y
43.54%
3Y*
-5.79%
5Y*
-16.04%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SYNGENE.NS vs. 2269.HK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SYNGENE.NS
SYNGENE.NS Risk / Return Rank: 22
Overall Rank
SYNGENE.NS Sharpe Ratio Rank: 00
Sharpe Ratio Rank
SYNGENE.NS Sortino Ratio Rank: 22
Sortino Ratio Rank
SYNGENE.NS Omega Ratio Rank: 22
Omega Ratio Rank
SYNGENE.NS Calmar Ratio Rank: 55
Calmar Ratio Rank
SYNGENE.NS Martin Ratio Rank: 11
Martin Ratio Rank

2269.HK
2269.HK Risk / Return Rank: 6060
Overall Rank
2269.HK Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
2269.HK Sortino Ratio Rank: 5757
Sortino Ratio Rank
2269.HK Omega Ratio Rank: 5858
Omega Ratio Rank
2269.HK Calmar Ratio Rank: 6161
Calmar Ratio Rank
2269.HK Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SYNGENE.NS vs. 2269.HK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Syngene International Limited (SYNGENE.NS) and WuXi Biologics (2269.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SYNGENE.NS2269.HKDifference

Sharpe ratio

Return per unit of total volatility

-1.45

0.83

-2.27

Sortino ratio

Return per unit of downside risk

-2.05

1.32

-3.37

Omega ratio

Gain probability vs. loss probability

0.72

1.19

-0.46

Calmar ratio

Return relative to maximum drawdown

-0.94

1.28

-2.22

Martin ratio

Return relative to average drawdown

-2.06

3.16

-5.23

SYNGENE.NS vs. 2269.HK - Sharpe Ratio Comparison

The current SYNGENE.NS Sharpe Ratio is -1.45, which is lower than the 2269.HK Sharpe Ratio of 0.83. The chart below compares the historical Sharpe Ratios of SYNGENE.NS and 2269.HK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


SYNGENE.NS2269.HKDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.45

0.83

-2.27

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.24

-0.25

+0.01

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

0.32

0.36

-0.04

Correlation

The correlation between SYNGENE.NS and 2269.HK is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

SYNGENE.NS vs. 2269.HK - Dividend Comparison

SYNGENE.NS's dividend yield for the trailing twelve months is around 0.32%, while 2269.HK has not paid dividends to shareholders.


TTM2025202420232022202120202019201820172016
SYNGENE.NS
Syngene International Limited
0.32%0.19%0.15%0.18%0.17%0.00%0.00%0.16%0.18%0.18%0.18%
2269.HK
WuXi Biologics
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

SYNGENE.NS vs. 2269.HK - Drawdown Comparison

The maximum SYNGENE.NS drawdown since its inception was -58.78%, smaller than the maximum 2269.HK drawdown of -92.11%. Use the drawdown chart below to compare losses from any high point for SYNGENE.NS and 2269.HK.


Loading graphics...

Drawdown Indicators


SYNGENE.NS2269.HKDifference

Max Drawdown

Largest peak-to-trough decline

-58.78%

-92.95%

+34.17%

Max Drawdown (1Y)

Largest decline over 1 year

-47.85%

-28.29%

-19.56%

Max Drawdown (5Y)

Largest decline over 5 years

-58.78%

-92.95%

+34.17%

Max Drawdown (10Y)

Largest decline over 10 years

-58.78%

Current Drawdown

Current decline from peak

-58.10%

-75.98%

+17.88%

Average Drawdown

Average peak-to-trough decline

-13.35%

-42.31%

+28.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.70%

14.73%

+6.97%

Volatility

SYNGENE.NS vs. 2269.HK - Volatility Comparison

The current volatility for Syngene International Limited (SYNGENE.NS) is 12.37%, while WuXi Biologics (2269.HK) has a volatility of 14.50%. This indicates that SYNGENE.NS experiences smaller price fluctuations and is considered to be less risky than 2269.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


SYNGENE.NS2269.HKDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.37%

14.50%

-2.13%

Volatility (6M)

Calculated over the trailing 6-month period

22.80%

31.30%

-8.50%

Volatility (1Y)

Calculated over the trailing 1-year period

31.10%

54.28%

-23.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.97%

66.82%

-38.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.38%

60.25%

-30.87%

Financials

SYNGENE.NS vs. 2269.HK - Financials Comparison

This section allows you to compare key financial metrics between Syngene International Limited and WuXi Biologics. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. SYNGENE.NS values in INR, 2269.HK values in HKD